Molecular profiling of pancreatic neuroendocrine tumors in sporadic and von Hippel-Lindau patients Full Text
Clinical Cancer Research, 04/04/2012
Speisky D et al. – This study shows that the progression of PanNET in Von Hippel–Lindau (VHL) patients tumors follows a specific pathway and supports that targeting molecules specifically involved may be of therapeutic importance.



